Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stéphanie Tardy"'
Autor:
Amira Marouf, Sammara Chaubard, Jean Marie Michot, Julien Rossignol, Camille Golfier, Olivier Allangba, Laure Philippe, Benoit Tessoulin, Adrien Chauchet, Bénédicte Deau, Lucie Oberic, Jacques Vargaftig, Aline Moignet, Aline Clavert, Rémy Duléry, Gabriel Brisou, Stéphanie Tardy, Virginie Fataccioli, Roch Houot, Rene Olivier Casasnovas, Catherine Thieblemont, Herve Ghesquieres, Sylvain Carras, Steven Le Gouill, Guillaume Cartron, Aurélien Marabelle, Olivier Tournilhac, Gandhi Laurent Damaj, Philippe Gaulard, Laurence De Leval, Francois Lemonnier, Emmanuel Bachy, Olivier Hermine, Lucile Couronné, Arnaud Jaccard
Publikováno v:
HemaSphere, Vol 7, p e41118bf (2023)
Externí odkaz:
https://doaj.org/article/e33362dfb2354a62a968dabc1e6fcb1d
Autor:
Guillemette Fouquet, Stéphanie Tardy, Hélène Demarquette, Sarah Bonnet, Julie Gay, Houria Debarri, Charles Herbaux, Stéphanie Guidez, Jessica Michel, Aurore Perrot, Caroline Serrier, Darko Miljkovic, Hervé Avet Loiseau, Thierry Facon, Cyrille Hulin, Xavier Leleu
Publikováno v:
Cancer. 119:3680-3686
BACKGROUND: Lenalidomide in combination with dexamethasone (Len=Dex) is indicated for patients with recurrent=refractory multiple myeloma (RRMM) who were treated with 1 prior therapy until evidence of disease progression. The objective of the current
Autor:
Stéphanie Tardy, Murielle Roussel, Sabine Revuz, Caroline Bonmati, Guillemette Fouquet, Oana Balasanu, Michel Attal, Pierre Feugier, Aurore Perrot, Jessica Michel, Dana Ranta, Serge Bologna, Xavier Leleu, Cyrille Hulin, Thierry Facon
Publikováno v:
Blood. 120:4075-4075
Abstract 4075 Introduction. The association of Melphalan-Prednisone and Thalidomide (MPT) is approved as first-line treatment in elderly patients with Multiple Myeloma (MM). This treatment demonstrated significant benefit in terms of overall survival
Autor:
Guillemette Fouquet, Stéphanie Tardy, Helene Demarquette, Sarah Bonnet, Julie Gay, Houria Debarri, Charles Herbaux, Jessica Michel, Aurore Perrot, Caroline Serrier, Suzanne K. Robinson, Darko Miljkovic, Pascale Morel, Catherine Boccacio, Herve AvetLoiseau, Thierry Facon, Cyrille Hulin, Xavier Leleu
Publikováno v:
Blood. 120:2964-2964
Abstract 2964 Background. Lenalidomide is an oral IMiD®, immunomodulatory compound, approved for use in combination with dexamethasone (Len/Dex) in patients with RRMM who have received one prior therapy. Len/Dex is indicated until evidence of diseas
Autor:
Marion Loirat, Cyrille Hulin, Thomas Gastinne, Philippe Moreau, Cyrille Touzeau, Stéphanie Tardy, Cédric Rossi, Caroline Legouge, Denis Caillot, Ingrid Lafon, Lucie Planche, Jessica Michel, Emilie Lemieux, Véronique Dorvaux
Publikováno v:
Biology of Blood and Marrow Transplantation. (3):445-449
Eighty-one patients treated with high-dose therapy and autologous stem cell transplantation (ASCT) as part of salvage therapy after a frontline ASCT were included in a retrospective analysis. The median time between the first and the salvage ASCT was